Duloxetine reduced the frequency of stress urinary incontinence episodes and improved quality of life in European women

Evidence-based Obstetrics and Gynecology

Volumn 6, Issue 4, 2004, Pages 196-199

  Millard, R J ^b   Moore, K ^b   Rencken, R ^b   Yalcin, I ^b   Bump, R C ^b   Chancellor, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; EPHEDRINE; IMIPRAMINE; PHENYLPROPANOLAMINE; PLACEBO; PSEUDOEPHEDRINE;

ARTICLE; BLEEDING DISORDER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; DIAGNOSTIC TEST; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FREQUENCY ANALYSIS; HEADACHE; HUMAN; INSOMNIA; MUSCLE TRAINING; NAUSEA; PELVIS FLOOR; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; STRESS INCONTINENCE; STROKE; URODYNAMICS; UROLOGIC SURGERY; XEROSTOMIA;

EID: 10244243857     PISSN: 1361259X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ebobgyn.2004.08.006     Document Type: Article

References (3)

1. Thor KB Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat J Pharmacol Exp Ther 1995 274 1014-1024
2. Yalcin I Versi E Benson JT et al. Validation of a clinical algorithm to diagnose stress urinary incontinence for large studies J Urol 2004 171 2321-2325
3. Muram D. Personal communication. Eli Lilly and Company